Physician profile
Michael J Morrison
NPI 1326030859
$573.46
in general payments reported to CMS, 2019-2025
16 companies · $80.04 in 2025
The $80.04 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $121 · 2021: $91.48 · 2022: $105 · 2023: $14.12 · 2024: $19.71 · 2025: $80.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $153.77 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $52.16 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $49.58 | 2020-2022 | |
| Bioventus LLC | $45.58 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Pfizer INC. | $40.95 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $36.81 | 2021 | |
| Mimedx Group, INC. | $32.83 | 2025 | |
| Depuy Synthes Sales INC. | $30.06 | 2022 | |
| Fidia Pharma USA INC. | $25.16 | 2025 | Hymhyn |
| Vertex Pharmaceuticals Incorporated | $22.05 | 2025 | |
| Horizon Therapeutics Plc | $15.37 | 2020 | |
| Kaleo, INC. | $14.91 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.54 | 2019 | |
| Forte Bio-Pharma LLC | $14.12 | 2023 | Prolate, Nalocet |
| Ultragenyx Pharmaceutical INC. | $13.91 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.